Paulus Stoffels

Chief Scientific Officer, Johnson & Johnson.

Companies

Takeda Pharmaceutical CompanyBoard member Jul 6, 2026 to now¹
Johnson & JohnsonChief Scientific Officer Oct 5, 2012 to Feb 17, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Takeda Pharmaceutical Company TAK3,800 shares³$74.6K at $19.64Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 1, 2026Granted 3,800 shares of Takeda Pharmaceutical Company³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTakeda Pharmaceutical Company, Board member
2
SEC EDGARJohnson & Johnson, Chief Scientific Officer
3
SEC EDGARTakeda Pharmaceutical Company shares after the filing of Jul 1, 2026